Phase 1 clinical trial investigating the safety, pharmacokinetics, pharmacodynamics, and antitumor activity of AB821 in adult patients with locally advanced or metastatic melanoma and other solid tumor malignancies (NCT 07027488).

AB821 - Asher Biotherap

https://www.asco.org/abstracts-presentations/266809

Harriet Kluger; David Braun; Ivana Djuretic; Michael Hurwitz; Jeffrey Ishizuka; David Schoenfeld; Mario Sznol; Mark Sayles; Thuy Tran

Apr 21, 2026